当前位置: 首页 > 期刊 > 《世界华人消化杂志》 > 2007年第3期
编号:11358348
脂联素与非酒精性脂肪肝病
http://www.100md.com 石胜利, 聂玉强
脂联素;脂联素受体;非酒精性脂肪肝;发病机制,石胜利,聂玉强,通讯作者:,Roleofadiponectininnonalcoholicfattyliverdisease,Sheng-LiShi,Yu-QiangNie,Correspondenceto:
第1页

    参见附件(761KB,4页)。

     石胜利, 广山市小榄人民医院消化科 广东省中山市 528415

    聂玉强,
广州医学院附属市一人民医院消化科 广东省广州市 510180

    通讯作者:
石胜利, 528415, 广东省中山市, 中山市小榄人民医院消化科. shishengli2004@163.com

    电话: 0760-8662120-6356

    收稿日期: 2006-10-17 接受日期: 2006-11-02

    Role of adiponectin in nonalcoholic fatty liver disease

    
Sheng-Li Shi, Yu-Qiang Nie

    Sheng-Li Shi,
Department of Gastroenterology, Xiaolan People’s Hospital, Zhongshan 528415, Guangdong Province, China

    Yu-Qiang Nie,
Department of Gastroenterology, the First Municipal People’s Hospital, Guangzhou Medical College, Guangzhou 510180, Guangdong Province, China

    Correspondence to:
Sheng-Li Shi, Department of Gastroenterology, People’s Hospital of Xiaolan, Zhongshan 28415, Guangdong Province, China. shishengli2004@163.com

    Received:
2006-10-17 Accepted:2006-11-02

    Abstract

    Adiponectin, discovered recently, is kind of adipose hormone that is secreted by adipose cells, and its serum level is lower in patients with adiposity, diabetes mellitus, and nonalcoholic fatty liver disease (NAFLD) than that in healthy individuals. Plasma adiponectin is in close correlation with the sensitivity of insulin and play an important role in insulin resistance. Meanwhile, adiponectin can inhibit the production of liver tumor necrosis factor-alpha and reduce the lipid accumulation and inflammatory reaction during liver injury. Therefore, we assessed the relationship between adiponectin and NAFLD in order to explore the role of adiponectin in the pathogenesis and treatment of NADLD.

    Key Words: Adiponectin; Adiponectin Receptor; Nonalcoholic fatty liver disease; Pathogenic mechanism

    Shi SL, Nie YQ. Role of adiponectin in nonalcoholic fatty liver disease. Shijie Huaren Xiaohua Zazhi 2007;15(3):272-275

    摘要

    脂联素(adiponectin, ADP)作为一种新发现的脂肪激素, 主要是由脂肪细胞分泌的, 在肥胖者、糖尿病及非酒精性脂肪性肝病(nonalcoholic fatty liver disease, NAFLD)患者中血清ADP水平低于正常. ADP有胰岛素增敏作用, 与胰岛素抵抗相关; 能够使肝脏肿瘤坏死因子(tumor necrosis factor-alpha, TNF-α)分泌下降, 减少肝中脂肪堆积和炎症介质作用, 对ADP的研究将为探讨NAFLD的发病机制及治疗方案提供新的线索 ......

您现在查看是摘要介绍页,详见PDF附件(761KB,4页)